8042 InSync III
Cardiac Resynchronization Therapy - Pacing (CRT-Pacing)
8042 InSync III
Information

Device Survival Probability

8042_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr at 121.0 mo                    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 99.9 99.9 99.9 99.7 99.4 99.1 98.8 98.7                    
% Including Normal Battery Depletion 99.4 99.1 98.2 96.0 92.3 85.4 73.5 55.6 36.5 17.2 13.7                    
#   30582 26210 22533 19260 16077 12306 8766 5667 2328 224 109                    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type CRT-Pacing
NBD Code DDDR
Max. Delivered Energy N/A
More
Connector Style CRT-P Style
Serial Number Prefix PKF
Mass 26 g
Volume 16 cc
Waveform N/A
X-Ray ID PKF
Hide this content
CRT-P Style
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 8.3 9.9
Nominal 3.5 V (A, RV) 5.9 7.8
High 5.0 V (A, RV) 4.1 6.0
Footnote

Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; Left Ventricle Pulse Width 0.4 ms; Left Ventricle Pulse Amplitude same as A, RV; Left Ventricle Percent Paced 100 %; Left Ventricle Lead Impedance same as A, RV; Atrial Fib Percent of Time 0 %; Hide this content

Information

Distribution Data

US Market Release2003-02-25
CE Approval Date2001-02-07
Registered USA Implants39511
Estimated Active USA Implants5030
Normal Battery Depletions5037
US Market Release2003-02-25
CE Approval Date2001-02-07
Estimated WW Distribution96029
Normal Battery Depletions5427
Information

Malfunctions (USA)

Therapy Function Not Compromised 61
Battery 49
Electrical Component 2
Electrical Interconnect 3
Possible Early Battery Depletion 2
Other 5
Therapy Function Compromised 43
Battery 31
Electrical Interconnect 12
Information

Malfunctions (WW)

Therapy Function Not Compromised 124
Battery 104
Electrical Component 8
Electrical Interconnect 5
Possible Early Battery Depletion 2
Other 5
Therapy Function Compromised 77
Battery 45
Electrical Component 3
Electrical Interconnect 29
Information

EOL Indication

From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Elective Replacement (ERI)

Telemetry indication. Rate and Mode change to 65 ppm and VVI (VOO/65 with magnet).

Data as of April 11, 2019

www.medtronic.com/productperformance 651050